The US Food and Drug Administration (FDA) has authorized a third booster dose of the Pfizer-BioNTech COVID-19 vaccine for Americans over 65 years of age and those suffering from serious illness.
The booster dose has also been approved for employees in certain occupations, such as health care workers, teachers, grocery store employees, and those in homeless shelters or prisons.
The authorization is likely to pave the way for a vote Thursday in the Centers for Disease Control and Prevention (CDC) advisory commission.
An FDA panel last week voted overwhelmingly to reject the White House plan to make the third dose available to most Americans, citing a lack of complete data on the safety of the third dose. as well as its effectiveness.
The panel nevertheless supported the booster dose for the over 65 age group and for individuals at high risk for serious illness.
The scientists stressed that the main concern should continue to be the vaccination of those who have not received any dose.
Meanwhile, according to a new study, pregnant women who are vaccinated against COVID-19 transmit coronavirus antibodies to unborn children.
Researchers at New York University’s Grossman School of Medicine examined 36 newborns whose mothers had received either the Pfizer or Moderna vaccine before birth and found that each baby had antibodies.
The study does not determine how strong the protection of infants from COVID-19 was, or how long it could last./VOA
To be part of the group »AOL“just click: Join Group and your request will be approved immediately.